Neuraptive Therapeutics, Inc.

New Filing
CIK: 0001713836·Biotechnology·DELAWARE·Filed: Apr 17, 2019
Total Offering

$12,499,998

Amount Sold

$10,224,998

Investors

5

First Sale

Dec 18, 2018

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
David Jackson
Related Person
Gino DiSciullo
Related Person
Greg Parekh
Related Person
Ivan Gergel
Related Person
Randy Hubbell
Related Person

Company

Neuraptive Therapeutics, Inc.

168 CTC Blvd

Louisville, CO, 80027

303-736-9657

SEC Filing

0001713836-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Neuraptive Therapeutics, Inc. Form D Filing — $12,499,998 | FilingFlow